Biochip Technology for the Serological Diagnosis of Bullous Pemphigoid

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">Autoantibody</td><td align="center">Number of positive cases</td><td align="center">Percentage of positive cases</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">ANTI-BP180-NC16a<br/></td><td align="center">15/18</td><td align="center">83.33</td></tr><tr><td align="left">ANTI-BP230-gC</td><td align="center">7/18</td><td align="center">39%</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

International Scholarly Research Notices

tab2

Table 2

Table 2: Biochip Technology for the Serological Diagnosis of Bullous Pemphigoid 